Excelera has announced the appointment of Lorrie A. Carr as its new CEO. Ms. Carr succeeds Jim Fox who retired effective April 2. She assumed her responsibilities on July 9th.
“After a thorough and deliberate selection process, the Board of Directors is delighted that Lorrie will lead Excelera as we navigate the dynamic and evolving specialty pharmacy industry,” said Robert Beacher, Chairman of the Board and interim CEO for Excelera. “Lorrie has a very diverse background within the biopharma and specialty pharmacy sectors, which will allow her to build upon our industry-leading position supporting our Members in caring for complex patients. I have no doubt that she is the right person to lead Excelera into new and innovative growth opportunities.”
Prior to joining Excelera, Ms. Carr was the Chief Commercial Officer for ZappRx – a healthcare technology company whose mission is to alleviate barriers that prevent patient access to life-saving specialty medications. Before ZappRx, Ms. Carr held an executive role within Walgreens Specialty Pharmacy as the Divisional VP of Enterprise Specialty Sales and Product Management. Ms. Carr started her career in the biopharmaceutical industry where she held leadership roles in global market access, reimbursement, managed care, marketing and network development.
“It is my great privilege to have been chosen to lead an innovative specialty healthcare company like Excelera,” said Carr. “I am honored to have the opportunity to work with a team of very talented employees and an industry-leading Board of Directors. As CEO, my primary objectives will be to continue the great work that has been started, develop innovative strategies designed to grow and leverage our membership, and build meaningful partnerships with biopharmaceutical clients.”
Ms. Carr received her bachelor’s degree from Columbia College and holds her MBA from UMASS Isenberg School of Management.